RxDoctor Payments Data

Michael Niccole

Newport Beach, CANPI 1801010475

Payments from drug & device makers

$95,273in general payments, 2019–2025

Across 217 payments — averaging $439.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$91K
  • Sientra, Inc.$2K
  • Merz North America, Inc.$1K
  • Mentor Worldwide LLC$369
  • Acera Surgical, Inc.$148
  • Boston Scientific$134
  • plus $457 from 7 others

What the payments were for

  • Speaking & faculty fees$63,16966%
  • Food & beverage$6,5957%
  • Education$80%
  • Gifts$25,50127%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin Hcl38$217
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen23$134
Ondansetron OdtOndansetron27$101

Paid to pharmacies, not to this prescriber.

Where these figures come from

Is this you, or does something look wrong? →